- MyIllumina
- Tools
The HumanOmni2.5S (Omni2.5S) BeadChip (Figure 1) provides over two million powerful markers selected from the 1000 Genomes Project (1kGP), targeting genetic variation down to 1% minor allele frequency (MAF). This content can be added to ongoing studies with Omni arrays for a total of up to 5 million markers per sample. The Omni2.5S can also be used as a standalone product to target the latest rare variants from the 1kGP. A semi-custom version of the BeadChip is also available, which can be tailored with up to 500K custom markers.
View the product support page for additional technical information ยป
View the Omni Family of Microarrays »
Catalog IDs: WG-311-2505, WG-311-2506, WG-311-2507, WG-311-2508, WG-311-2509, WG-311-2510, WG-311-2535, WG-311-2536
Product Literature
| HumanOmni2.5S Data Sheet |
| Omni Microarrays Brochure |
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.